A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies.

A desirable but as yet unachieved property of a human immunodeficiency virus type 1 (HIV-1) vaccine candidate is the ability to induce broadly neutralizing antibodies (bNAbs). One approach to the problem is to create trimeric mimics of the native envelope glycoprotein (Env) spike that expose as many...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rogier W Sanders, Ronald Derking, Albert Cupo, Jean-Philippe Julien, Anila Yasmeen, Natalia de Val, Helen J Kim, Claudia Blattner, Alba Torrents de la Peña, Jacob Korzun, Michael Golabek, Kevin de Los Reyes, Thomas J Ketas, Marit J van Gils, C Richter King, Ian A Wilson, Andrew B Ward, P J Klasse, John P Moore
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
Acceso en línea:https://doaj.org/article/3e5c50044db042828a59840116a3f458
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3e5c50044db042828a59840116a3f458
record_format dspace
spelling oai:doaj.org-article:3e5c50044db042828a59840116a3f4582021-11-18T06:07:37ZA next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies.1553-73661553-737410.1371/journal.ppat.1003618https://doaj.org/article/3e5c50044db042828a59840116a3f4582013-09-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24068931/pdf/?tool=EBIhttps://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374A desirable but as yet unachieved property of a human immunodeficiency virus type 1 (HIV-1) vaccine candidate is the ability to induce broadly neutralizing antibodies (bNAbs). One approach to the problem is to create trimeric mimics of the native envelope glycoprotein (Env) spike that expose as many bNAb epitopes as possible, while occluding those for non-neutralizing antibodies (non-NAbs). Here, we describe the design and properties of soluble, cleaved SOSIP.664 gp140 trimers based on the subtype A transmitted/founder strain, BG505. These trimers are highly stable, more so even than the corresponding gp120 monomer, as judged by differential scanning calorimetry. They are also homogenous and closely resemble native virus spikes when visualized by negative stain electron microscopy (EM). We used several techniques, including ELISA and surface plasmon resonance (SPR), to determine the relationship between the ability of monoclonal antibodies (MAbs) to bind the soluble trimers and neutralize the corresponding virus. In general, the concordance was excellent, in that virtually all bNAbs against multiple neutralizing epitopes on HIV-1 Env were highly reactive with the BG505 SOSIP.664 gp140 trimers, including quaternary epitopes (CH01, PG9, PG16 and PGT145). Conversely, non-NAbs to the CD4-binding site, CD4-induced epitopes or gp41ECTO did not react with the trimers, even when their epitopes were present on simpler forms of Env (e.g. gp120 monomers or dissociated gp41 subunits). Three non-neutralizing MAbs to V3 epitopes did, however, react strongly with the trimers but only by ELISA, and not at all by SPR and to only a limited extent by EM. These new soluble trimers are useful for structural studies and are being assessed for their performance as immunogens.Rogier W SandersRonald DerkingAlbert CupoJean-Philippe JulienAnila YasmeenNatalia de ValHelen J KimClaudia BlattnerAlba Torrents de la PeñaJacob KorzunMichael GolabekKevin de Los ReyesThomas J KetasMarit J van GilsC Richter KingIan A WilsonAndrew B WardP J KlasseJohn P MoorePublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 9, Iss 9, p e1003618 (2013)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
spellingShingle Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
Rogier W Sanders
Ronald Derking
Albert Cupo
Jean-Philippe Julien
Anila Yasmeen
Natalia de Val
Helen J Kim
Claudia Blattner
Alba Torrents de la Peña
Jacob Korzun
Michael Golabek
Kevin de Los Reyes
Thomas J Ketas
Marit J van Gils
C Richter King
Ian A Wilson
Andrew B Ward
P J Klasse
John P Moore
A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies.
description A desirable but as yet unachieved property of a human immunodeficiency virus type 1 (HIV-1) vaccine candidate is the ability to induce broadly neutralizing antibodies (bNAbs). One approach to the problem is to create trimeric mimics of the native envelope glycoprotein (Env) spike that expose as many bNAb epitopes as possible, while occluding those for non-neutralizing antibodies (non-NAbs). Here, we describe the design and properties of soluble, cleaved SOSIP.664 gp140 trimers based on the subtype A transmitted/founder strain, BG505. These trimers are highly stable, more so even than the corresponding gp120 monomer, as judged by differential scanning calorimetry. They are also homogenous and closely resemble native virus spikes when visualized by negative stain electron microscopy (EM). We used several techniques, including ELISA and surface plasmon resonance (SPR), to determine the relationship between the ability of monoclonal antibodies (MAbs) to bind the soluble trimers and neutralize the corresponding virus. In general, the concordance was excellent, in that virtually all bNAbs against multiple neutralizing epitopes on HIV-1 Env were highly reactive with the BG505 SOSIP.664 gp140 trimers, including quaternary epitopes (CH01, PG9, PG16 and PGT145). Conversely, non-NAbs to the CD4-binding site, CD4-induced epitopes or gp41ECTO did not react with the trimers, even when their epitopes were present on simpler forms of Env (e.g. gp120 monomers or dissociated gp41 subunits). Three non-neutralizing MAbs to V3 epitopes did, however, react strongly with the trimers but only by ELISA, and not at all by SPR and to only a limited extent by EM. These new soluble trimers are useful for structural studies and are being assessed for their performance as immunogens.
format article
author Rogier W Sanders
Ronald Derking
Albert Cupo
Jean-Philippe Julien
Anila Yasmeen
Natalia de Val
Helen J Kim
Claudia Blattner
Alba Torrents de la Peña
Jacob Korzun
Michael Golabek
Kevin de Los Reyes
Thomas J Ketas
Marit J van Gils
C Richter King
Ian A Wilson
Andrew B Ward
P J Klasse
John P Moore
author_facet Rogier W Sanders
Ronald Derking
Albert Cupo
Jean-Philippe Julien
Anila Yasmeen
Natalia de Val
Helen J Kim
Claudia Blattner
Alba Torrents de la Peña
Jacob Korzun
Michael Golabek
Kevin de Los Reyes
Thomas J Ketas
Marit J van Gils
C Richter King
Ian A Wilson
Andrew B Ward
P J Klasse
John P Moore
author_sort Rogier W Sanders
title A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies.
title_short A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies.
title_full A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies.
title_fullStr A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies.
title_full_unstemmed A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies.
title_sort next-generation cleaved, soluble hiv-1 env trimer, bg505 sosip.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/3e5c50044db042828a59840116a3f458
work_keys_str_mv AT rogierwsanders anextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT ronaldderking anextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT albertcupo anextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT jeanphilippejulien anextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT anilayasmeen anextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT nataliadeval anextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT helenjkim anextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT claudiablattner anextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT albatorrentsdelapena anextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT jacobkorzun anextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT michaelgolabek anextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT kevindelosreyes anextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT thomasjketas anextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT maritjvangils anextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT crichterking anextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT ianawilson anextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT andrewbward anextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT pjklasse anextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT johnpmoore anextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT rogierwsanders nextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT ronaldderking nextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT albertcupo nextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT jeanphilippejulien nextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT anilayasmeen nextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT nataliadeval nextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT helenjkim nextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT claudiablattner nextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT albatorrentsdelapena nextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT jacobkorzun nextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT michaelgolabek nextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT kevindelosreyes nextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT thomasjketas nextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT maritjvangils nextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT crichterking nextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT ianawilson nextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT andrewbward nextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT pjklasse nextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
AT johnpmoore nextgenerationcleavedsolublehiv1envtrimerbg505sosip664gp140expressesmultipleepitopesforbroadlyneutralizingbutnotnonneutralizingantibodies
_version_ 1718424530944262144